| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Structure Therapeutics Inc. | Director | Share Option (right to buy) | 51.8K | 23 Jun 2025 | Direct | ||
| CATALYST BIOSCIENCES, INC. | Director | Stock Option (Right to Buy) | 14K | 09 Jun 2021 | Direct | ||
| DICE Therapeutics, Inc. | Director | Common Stock | 0 | $46.50 | 09 Aug 2023 | Direct | |
| DICE Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | 09 Aug 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GPCR | Structure Therapeutics Inc. | 23 Jun 2025 | 1 | $0 | 4 | Director | 25 Jun 2025, 17:45 |
| GPCR | Structure Therapeutics Inc. | 25 Jun 2024 | 1 | $0 | 4 | Director | 27 Jun 2024, 16:15 |
| DICE | DICE Therapeutics, Inc. | 09 Aug 2023 | 5 | $0 | 4 | Director | 09 Aug 2023, 16:38 |
| GPCR | Structure Therapeutics Inc. | 02 Feb 2023 | 0 | $0 | 3 | Director | 02 Feb 2023, 17:26 |
| DICE | DICE Therapeutics, Inc. | 07 Jun 2022 | 1 | $0 | 4 | Director | 08 Jun 2022, 17:06 |
| DICE | DICE Therapeutics, Inc. | 14 Sep 2021 | 4 | $0 | 4 | Director | 16 Sep 2021, 21:28 |
| DICE | DICE Therapeutics, Inc. | 14 Sep 2021 | 0 | $0 | 3 | Director | 14 Sep 2021, 19:27 |
| CBIO | CATALYST BIOSCIENCES, INC. | 09 Jun 2021 | 1 | $0 | 4 | Director | 02 Jul 2021, 09:55 |